|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 413/14 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| C07D 491/048 | |||
| C07D 491/052 | |||
| C07D 495/04 | |||
| A61K 31/551 | |||
| A61P 3/04 | |||
| A61P 25/20 | |||
| C07D 403/14 |
| (11) | Number of the document | 2392572 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11177692.8 |
| Date of filing the European patent application | 2007-11-30 | |
| (97) | Date of publication of the European application | 2011-12-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 872393 P | 2006-12-01 | US | |
| 959742 P | 2007-07-16 | US |
| (72) |
Bergman, Jeffrey, M., US
Breslin, Michael, J., US
Coleman, Paul, J., US
Cox, Christopher, D., US
Mercer, Swati, P., US
Roecker, Anthony, J., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | Substituted diazepan compounds as orexin receptor antagonists |
| Substituted diazepan compounds as orexin receptor antagonists |